Related Experiment Video

Updated: Jul 23, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

28.4K

Characterization of the novel HLA-A*33:220 allele by next-generation sequencing

Grégory Gatouillat1, Thierry Tabary1, Marcelle Tonye-Libyh1

  • 1CHU Reims, Laboratoire d'immunologie, Reims, France.

HLA
|July 18, 2023
PubMed

Abstract:

HLA-A*33:220 differs from HLA-A*33:03:01:01 by one nucleotide substitution in codon 245 in exon 4.

Keywords:
HLA-A*33:220HLAnext-generation sequencingnovel allele

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.1K
High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

11.9K

Related Experiment Videos

Last Updated: Jul 23, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

28.4K
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.1K
High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

11.9K

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

91.6K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
91.6K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.6K
Multiple Allele Traits01:49

Multiple Allele Traits

34.4K
The Concept of Multiple Allelism
34.4K

Articles linked to this work by shared authors, journal, and citation graph.

Characterisation of the Novel HLA-DRB1*13:374 Allele by Next-Generation Sequencing.

HLA·2026

Characterisation of the Novel HLA-DQB1*06:03:58 Allele by Next-Generation Sequencing.

HLA·2026

Characterisation of the Novel HLA-C*07:01:124 Allele by Next-Generation Sequencing.

HLA·2026

Characterisation of the Novel HLA-DRB1*13:370N Allele by Next-Generation Sequencing.

HLA·2026

Characterisation of the Novel HLA-B*37:112N Allele by Next-Generation Sequencing.

HLA·2026

Characterisation of the Novel HLA-DQA1*05:65:01:01 Allele by Next-Generation Sequencing.

HLA·2026

Characterisation of the Novel HLA-A*03:541 Allele by Next-Generation Sequencing.

HLA·2026

Characterisation of the Novel HLA-DRB3*02:240 Allele by Sequencing-Based Typing.

HLA·2026

Characterisation of the Novel HLA-A*02:1205 and HLA-A*02:07:27 Alleles by Next-Generation Sequencing.

HLA·2026

The Novel HLA-A*02:1229 Allele Was Identified by Next-Generation Sequencing.

HLA·2026

A Novel Exonic Variant MICB*075 Was Identified in an Individual From Maharashtra, India.

HLA·2026

Characterisation of the Novel HLA-DQB1*02:80:02 Allele by Sequencing-Based Typing.

HLA·2026

Normal platelet function in a patient with ARHGEF1 deficiency.

Haematologica·2026

Erratum: Zero-profile interbody fusion in single and two-level anterior cervical discectomy and fusion: a novel surgical system and its indications.

Journal of spine surgery (Hong Kong)·2026

The Identification of the Novel HLA-B*18:01:01:98 Allele in an Individual From Western India.

HLA·2026

A 20-Year-Old Man With Disproportionate Chest Radiograph Abnormality.

CHEST pulmonary·2026

RETRACTED: Alam et al. Empirical Study of Autism Spectrum Disorder Diagnosis Using Facial Images by Improved Transfer Learning Approach. Bioengineering 2022, 9, 710.

Bioengineering (Basel, Switzerland)·2026

Atypical Presentation of Raine Syndrome in a Middle-aged Lady.

The Journal of the Association of Physicians of India·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us